28
Views
1
CrossRef citations to date
0
Altmetric
Patent Evaluation

Aminopyridines as protein kinase Cθ inhibitors

Boehringer Ingelheim: US20060217417

Pages 583-586 | Published online: 02 May 2007

Bibliography

  • BAIER G, TELFORD D, GIAMPA L et al.: Molecular cloning and characterization of PKCθ, a human novel member of the PKC gene family expressed predominantly in hematopoietic cells. J. Bio. Chem. (1993) 268:4997-5004.
  • CHANG JD, XU Y, RAYCHOWDHURY MK, WARE JA: Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase C (nPKC). J. Bio. Chem. (1993) 268:14208-14214.
  • ALTMAN A, VILLALBA M: Protein kinase C-θ (PKCθ): it is all about location, location, location. Immunol. Rev. (2003) 192:52-53.
  • SEDWICK C: Perspective on PKCθ in T cell activation. Mol. Immunol. (2004) 41:765-686.
  • LI Y, SOOS TJ, LI X et al.: Protein kinase C-θ inhibits insulin signaling by phosphorylating IRSI at Ser1101. J. Bio. Chem. (2004) 279:45304-45307.
  • Lilly delivers promising update to wall street on strategic priorities, pipeline progress and earnings guidance. Eli Lilly & Co. Press Release (2006) December 7.
  • GOTLIB J et al.: Phase II trial of the tyrosine kinase inhibitor PKC412 in advanced systemic mastocytosis: preliminary results. Blood (2006) 108:11.
  • Investigational treatment ruboxistaurin demonstrated promise in reducing the occurrence of vision loss caused by diabetic retinopathy. Eli Lilly & Co. Press Release (2006) June 11.
  • CYWIN CL, DAHMANN G, PROKOPOWICZ AS III et al.: Discovery of potent and selective PKC-θ inhibitors. Bioorg. Med. Chem. Lett. (2007) 17:225-230.
  • SALEK-ARDAKANI S, SOT, HALTEMAN BS, ALTMAN A, CROFT M: Protein kinase C-θ controls TH1 cells in experimental autoimmune encephalomyelitis. J. Immunology. (2005) 175:7635-7641.
  • TAN S-L, ZHAO J, BI C et al.: Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C-θ-deficient mice. J. Immunology. (2006) 176:2872-2879.
  • XU Z-B, CHAUDHARY D, OLLAND S et al.: Catalytic domain of crystal structure of protein kinase C-θ. J. Bio Chem. (2004) 279:50410-50409.

Patents

  • BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.: US20040242613 (2004).
  • BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.: US2006025433 (2006).
  • BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.: US20060217417 (2006).
  • AMGEN, INC.: US20050182072 (2005).
  • MILLENNIUM PHARMACEUTICALS, INC.: US20060040968 (2006).
  • NOVARTIS AG: WO2005039549 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.